Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP) After Review of Natpara Meeting

June 26, 2012 10:55 AM EDT Send to a Friend
Needham & Company reiterates a 'Buy' on NPS Pharmaceuticals Inc. (NASDAQ: NPSP) price target of $15.00.

Analyst, Alan Carr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login